Rongzhen Luo

1.8k total citations
55 papers, 1.1k citations indexed

About

Rongzhen Luo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rongzhen Luo has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Rongzhen Luo's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer-related gene regulation (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Rongzhen Luo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer-related gene regulation (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Rongzhen Luo collaborates with scholars based in China, United States and Netherlands. Rongzhen Luo's co-authors include Zhongyu Yuan, Shusen Wang, Roujun Peng, Cong Xue, Jing‐Ping Yun, Lili Liu, Xue Chao, Yue-Li Sun, Haixia Jiang and Jie‐Qiong Ma and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rongzhen Luo

52 papers receiving 1.1k citations

Peers

Countries citing papers authored by Rongzhen Luo

Since Specialization

Citations

This map shows the geographic impact of Rongzhen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongzhen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongzhen Luo more than expected).

Fields of papers citing papers by Rongzhen Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongzhen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongzhen Luo. The network helps show where Rongzhen Luo may publish in the future.

Co-authorship network of co-authors of Rongzhen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Rongzhen Luo. A scholar is included among the top collaborators of Rongzhen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongzhen Luo. Rongzhen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glycogen stores mediated by the p53-GYS1 feedback circuit engenders platinum resistance in ovarian clear cell carcinoma 2025 ·Cell Death and Differentiation ·Haoyu Liang, Rongzhen Luo, Ru Deng, Shi‐Lu Chen, Xuan Liu, Yang Xia, Lijun Wei, (unknown), Liyan Wu, (unknown), Jing‐Ping Yun, Lili Liu	1
2	Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours 2024 ·Pathology ·(unknown), Feng Chen, Lu Pan, Xue Chao, Mei Li, Rongzhen Luo, Keming Chen, Chengyou Zheng, Tian Du, Jiehua He, Peng Sun	4
3	The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages 2023 ·Cancer Cell International ·(unknown), Ting Wan, Yun Zhou, Shuting Huang, Linjing Yuan, (unknown), Xiaojing Zheng, Pingping Liu, (unknown), (unknown), Rongzhen Luo, Wei‐Hua Jia, Chunyan Lan, Jundong Li, Min Zheng	13
4	Metastasis of breast cancer to bones alters the tumor immune microenvironment 2023 ·European journal of medical research ·Xue Chao, Ying Zhang, Chengyou Zheng, Qitao Huang, Jiabin Lu, Emilia M. Pulver, Julia M. Houthuijzen, (unknown), Rongzhen Luo, Jiehua He, Peng Sun	10
5	Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Run‐Cong Nie, Lianghe Lu, (unknown), Dan Xie, Rongzhen Luo, Muyan Cai	12
6	PD-L1 expression, morphology, and molecular characteristic of a subset of aggressive uterine tumor resembling ovarian sex cord tumor and a literature review 2023 ·Journal of Ovarian Research ·Siping Xiong, Rongzhen Luo, (unknown), Xia Yang, (unknown), Chao Zhang, Lili Liu	12
7	Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers 2023 ·EBioMedicine ·Yini Huang, Yao Zhao, Lingling Li, Rushuang Mao, Weijun Huang, Zhengming Hu, Yixin Hu, Yun Wang, Ruohan Guo, Xiaofeng Tang, (unknown), Yuanyuan Wang, Rongzhen Luo, Jinhua Yu, Jianhua Zhou	39
8	The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes 2022 ·Cancer Cell International ·Xiaoying Sun, Lili Liu, Ting Wan, Qidan Huang, (unknown), Rongzhen Luo, (unknown)	11
9	Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin 2022 ·Breast Cancer Research ·Tian Du, Lu Pan, Chengyou Zheng, Keming Chen, Yuanzhong Yang, Jiewei Chen, Xue Chao, Mei Li, Jiabin Lu, Rongzhen Luo, Jinhui Zhang, Yu Wu, Jiehua He, (unknown), Peng Sun	13
10	HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis 2021 ·Cancer Cell International ·Rongzhen Luo, Shulin Chen, (unknown), Yue Li, Yang Xia, Lili Liu	5
11	A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer 2021 ·EBioMedicine ·Peng Sun, Jiehua He, Xue Chao, (unknown), Yuanyuan Xu, Qitao Huang, Jing‐Ping Yun, (unknown), Rongzhen Luo, Jinbo Kuang, Huajia Wang, Hao‐Sen Li, Hui Hui, Shuoyu Xu	40
12	Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications 2021 ·Journal of Hepatocellular Carcinoma ·Jin‐Ling Duan, Run‐Cong Nie, (unknown), Jiewei Chen, Minhua Deng, Hu L, Feng‐Wei Wang, Rongzhen Luo, Dan Xie, Muyan Cai	5
13	Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix 2021 ·BMC Cancer ·Shiwen Zhang, Rongzhen Luo, Xiaoying Sun, Yang Xia, Haixia Yang, Siping Xiong, Lili Liu	4
14	WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition 2016 ·PLoS ONE ·Yun Zhou, Yongwen Huang, Xinping Cao, Jing Xu, (unknown), Jianhua Wang, Long Huang, Shuting Huang, Linjing Yuan, (unknown), Xing-Juan Yu, Rongzhen Luo, Min Zheng	27
15	Expression of Cystatin SN significantly correlates with recurrence, metastasis and survival duration in surgically resected non-small cell lung cancer patients 2015 ·Scientific Reports ·Xun Cao, Yong Li, Rongzhen Luo, Lin Zhang, (unknown), Jun Zeng, Yujing Han, Zhesheng Wen	31
16	Decreased expression of light chain 3 (LC3) increased the risk of distant metastasis in triple-negative breast cancer 2013 ·Medical Oncology ·Jiehua He, Rongzhen Luo, Muyan Cai, Mei Li, (unknown), Zhongyu Yuan	12
17	Cordyceps militaris Extract Attenuates D-Galactose-Induced Memory Impairment in Mice 2012 ·Journal of Medicinal Food ·(unknown), Zhi Zhang, (unknown), Jing Jia, Jie Ding, Rongzhen Luo, (unknown)	11
18	Clinical Features and Outcomes of Head and Neck Castleman Disease 2012 ·Journal of Oral and Maxillofacial Surgery ·Yanfeng Chen, Weidong Zhang, (unknown), Dian Ouyang, (unknown), Rongzhen Luo, Mingwei Wu	7
19	Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma 2011 ·Journal of Surgical Oncology ·(unknown), (unknown), Rongzhen Luo, Ying Zhang, Meifang Zhang, Xin Wang, Wei‐Hua Jia	33
20	Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: A large cohort retrospective study 2009 ·Lung Cancer ·Li Zhang, Xue Hou, Shun Lü, Hui‐Lan Rao, Jinghui Hou, Rongzhen Luo, He Huang, Hongyun Zhao, Hong Jian, Zhiwei Chen, Meilin Liao, Xin Wang	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact